IMM and IMMP Related Headlines
Go Back- Immutep Receives A$4.6 million R&D Tax Incentive from French Government
- Immutep gets FDA feedback on head and neck cancer drug development
- Immutep Receives Positive Feedback from FDA on Late-Stage Clinical Development of Eftilagimod Alfa in Head and Neck Cancer with CPS <1
IMM and IMMP Related Press Releases
Go Back- Immutep Receives A$4.6 million R&D Tax Incentive from French Government
- Immutep Receives Positive Feedback from FDA on Late-Stage Clinical Development of Eftilagimod Alfa in Head and Neck Cancer with CPS <1
